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A B S T R A C T
Background: Little is known about anxiety in aged care populations, despite its increase in this frail population.
This study investigated the prevalence, recording, and treatment rate of anxiety disorders among aged care
residents.
Methods: A cross-sectional, observational design was used to assess 180 elderly residents from 12 aged care
facilities in Melbourne, Australia. Participants were assessed for threshold and subthreshold anxiety disorders
and comorbid depression using the MINI for DSM-5. Medical files were also reviewed to determine whether there
was any indication that anxiety had previously been detected, and what treatment those with a threshold/
subthreshold diagnosis were receiving.
Results: Overall prevalence of threshold and subthreshold anxiety disorders was 19.4% and 11.7%, respectively.
Generalized anxiety disorder was the most common threshold disorder and agoraphobia was the most prevalent
subthreshold anxiety disorder. While less than half of those with a threshold or subthreshold anxiety disorder
had an indication of anxiety in their file, the majority received psychotropic medication. Cognitive impairment
was not significantly associated with the prevalence or treatment of anxiety.
Conclusions: The prevalence of threshold and subthreshold anxiety in aged care settings is high, but remains
under-reported by staff and GPs. Facility staff and GPs should ensure they are aware of how anxiety presents in
elderly residents and routinely screen for this common mental health issue. This cohort had poor access to
psychological treatments for their condition.
1. Introduction
Anxiety disorders are the most common mental health issue in older
adults (≥ 65 years) (Gonçalves et al., 2011; Gum et al., 2009). Despite
this, there is limited research into their prevalence in residential aged
care facilities (RACFs; also known as nursing homes, hostels, assisted
living facilities, or long-term care/residential homes), with a review by
Creighton et al. (2015) finding only 10 studies addressing this im-
portant topic. These available studies indicated that anxiety disorders
are more prevalent in RACFs than in the community; with reports
ranging from 3.2% to 20.0% in aged care populations compared to
1.4–17.0% among older adults living in their own homes (Creighton
et al., 2015).
However, considerable inconsistency exists across studies in re-
ported prevalence rates for overall and specific anxiety disorders within
RACFs, making it difficult to draw firm conclusions. For instance,
Junginger et al. (1993) reported the overall prevalence of anxiety
disorders according to the Diagnostic and Statistical Manual of Mental
Disorders Third Edition, Revised (DSM-III-R; American Psychiatric
Association [APA], 1987) to be 20.0% and found generalised anxiety
disorder (GAD) to be the most prevalent specific disorder (6.0%). In
contrast, Cheok et al. (1996) reported an overall prevalence of 3.7%
and found specific phobia to be the most common (14.0%). Previous
studies utilised now outdated diagnostic systems and further research
utilising contemporary diagnostic criteria (i.e., the fifth edition of the
DSM (APA, 2013)) on the current cohort of older adults is urgently
needed. Moreover, many previous studies either excluded specific
conditions from their overall estimate (e.g., Cheok et al., 1996) or did
not report the prevalence of specific disorders (e.g., Arvaniti et al.,
2005; Forsell and Winblad, 1997; Jervis and Manson, 2007; Parmelee
et al., 1993). Similarly, most studies did not examine the relationship
between anxiety and depression, despite it being found to frequently co-
occur in elderly community samples (Braam et al., 2014; Byers et al.,
2010). Thus, research clarifying the prevalence of specific and overall
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anxiety disorders as well as the relationship between anxiety and de-
pression in RACFs is required to address this gap in current literature.
Also problematic is the lack of available studies investigating the
prevalence of subthreshold anxiety (i.e., anxiety not meeting full di-
agnostic criteria). The only published study within an aged care setting
located by the authors reported a lower prevalence of subthreshold
anxiety disorders than DSM-4 (APA, 1994) threshold disorders (4.2%
vs. 5.7%; Smalbrugge et al., 2005b). This is in contrast to higher rates of
subthreshold than threshold anxiety reported in community settings
(Grenier et al., 2012; Heun et al., 2000) and requires replication, given
the substantial negative impact of subthreshold disorders on func-
tioning and quality of life (van Zelst et al., 2006).
Given the paucity of research into prevalence rates within RACFs, it
is not surprising that little is known about the recording and treatment
of anxiety in this setting. Drageset et al. (2013) found only half of the
cognitively-intact RACF residents who reported anxiety symptoms had
a diagnosis on file, and less than half of those with a file diagnosis were
treated with an anxiolytic. Prior studies into the treatment of anxiety in
RACF residents have focused on the use of pharmacological interven-
tions only, with the most commonly used medications being anti-de-
pressants (48%) and anxiolytics (38–97%) (Bourgeois et al., 2012;
Selbæk et al., 2007), with no attention paid to documentation of psy-
chological treatments. As late-life anxiety can be effectively treated
using psychological as well as pharmacological treatments, particularly
if detected and treated early (Barlow and Comer, 2013), this gap re-
quires redress. Moreover, with previous research on depression in
RACFs finding cognitive impairment impedes detection (Evers et al.,
2002) and is associated with slightly lower treatment rates (Davison
et al., 2007), an understanding of its impact on the recognition and
treatment of anxiety is vital, particularly given that over half of aged
care residents have been found to have some level of cognitive im-
pairment (Onder et al., 2012; Selbæk et al., 2007).
To address the abovementioned gaps and limitations, this study
aimed to investigate the prevalence of DSM-5 (APA, 2013) threshold/
subthreshold anxiety disorders and comorbid depression in a sample of
elderly RACF residents with mild cognitive impairment and normal
cognitive function. The study also explored the treatment and reporting
rates of anxiety by GPs and RACF staff. Not only will this information
offer researchers and clinicians with a better understanding of the
current cohort of older adults living in aged care, it will also provide
better insights into the effectiveness of current aged care practices in
detecting and managing this treatable condition.
2. Methods
2.1. Study design
This study utilised an observational, cross-sectional design. Ethics
approval was granted by the Monash University Human Research Ethics
Committee.
2.2. Participants
Utilizing a formula by Daniel (1999) and recommended by Naing
et al. (2006), a sample size of 171 participants was determined ade-
quate to estimate population prevalence with 95% confidence. Re-
sidents were excluded if they: were<65 years old; resided at the RACF
for less than three months; scored< 18 on the Mini-Mental State Ex-
amination (MMSE); had a diagnosis of schizophrenia or bipolar affec-
tive disorder; or were unable to complete clinical assessments because
of illness, medication, sensory or speech impairment, intellectual dis-
ability, or lack of language fluency.
One-hundred and eighty participants were recruited between March
2015 and November 2016 at a randomly selected group of 12 RACFs
within southern and eastern regions of metropolitan Melbourne. Fig. 1
provides an overview of participant recruitment with reasons for
exclusion or refusal indicated.
2.3. Measurements
2.3.1. Demographic and medical information
Information on participants’ age, marital status, date of RACF ad-
mission, and current prescribed medications (regular and PRN) were
derived from their files held at the facility. Lists of medical diagnoses
and behaviour charts kept in each participant's file were also reviewed
to determine whether there was any indication of anxiety recorded by
facility staff, GPs, or other medical practitioners.
2.3.2. Depression and anxiety
The presence of current major depressive disorder (MDD) and
threshold and subthreshold anxiety disorders (panic disorder, social
anxiety disorder (SAD), agoraphobia, specific phobia, and generalized
anxiety disorder) was determined using the Mini-International
Neuropsychiatric Interview version 7.0.0 (MINI; Sheehan et al., 1998).
The MINI is a structured clinical interview that generates diagnoses
according to DSM-5 (APA, 2013) criteria, and has been widely used in
research and clinical settings. While not specifically developed for older
adults, this diagnostic measure has been previously used within RACF
settings (e.g., Arvaniti et al., 2005; Pachana et al., 2007). Two trained
interviewers administered the MINI, with the inter-rater reliability (as
measured by Cohen's kappa for a subset of 22 participants) being: 1.0
for panic disorder and agoraphobia, and 0.65 for GAD. Inter-rater re-
liability for MDD, SAD, and specific phobia could not be computed as
no participants in the subsample met criteria for a diagnosis. Training
on the use of this measure and continuous supervision was provided
throughout the study.
Subthreshold anxiety disorders were defined using criteria devel-
oped by Angst et al. (1997) and Heun et al. (2000) (Table 1), and ex-
trapolated using information derived from the MINI interview re-
sponses. These criteria have also been used in previous research
examining anxiety in an aged care population (e.g., Smalbrugge et al.,
2005b). Similar to Heun et al. (2000), subthreshold disorders could be
Fig. 1. Participant recruitment flowchart.
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diagnosed in participants with other threshold or subthreshold anxiety
disorders, but were only diagnosed if the related threshold diagnosis
was absent (i.e., subthreshold GAD was only diagnosed in participants
who did not meet criteria for threshold GAD).
2.3.3. Cognitive functioning
Cognitive functioning was assessed using the Mini-Mental State
Examination (MMSE; Folstein et al., 1975); a commonly used, brief
cognitive screening instrument comprising 11-items assessing orienta-
tion, memory recall, attention, language, comprehension, and visuos-
patial skills. The MMSE provides an overall score out of 30, with
commonly accepted cut-off points being: 24–30 for normal cognition;
18–23 for mild cognitive impairment; and 0–17 for moderate to severe
cognitive impairment (Tombaugh and McIntyre, 1992).
2.4. Procedure
Using a random number generator, 19 RACFs were randomly se-
lected from a list of all facilities within southern and eastern me-
tropolitan Melbourne, and invited to participate via phone call and
email. Twelve facilities agreed to participate and included private
companies, non-for-profit and religious organizations, and government
funded facilities. Screening and identification of potential participants
was completed with the assistance of the manager and/or director of
nursing of each participating facility. Eligible residents were then ap-
proached by the first author (AC) and completed a process developed by
Warner et al. (2008) to determine their capacity to provide informed
consent. If deemed able to provide informed consent, they were invited
to participate in the study and sign the consent form. For those con-
sidered unable to provide consent themselves, the ‘person responsible’
was approached to provide written informed consent. The MMSE was
then administered, with residents scoring<18 excluded from the
study, as well as residents who met other exclusion criteria. All parti-
cipants were administered the MINI to determine the presence/absence
of MDD and threshold/subthreshold anxiety disorders.
2.5. Statistical analysis
Data was collated and analyzed using the Statistical Package for
Social Sciences (SPSS) version 22. Percentages were calculated to es-
timate the prevalence of MDD, threshold/subthreshold anxiety dis-
orders, and comorbid MDD and anxiety. As recommended by Brase and
Brase (2017), 95% confidence intervals (CI) were calculated using the
normal approximation method in the first instance, and Wilson estimate
if np ≤10 or n(1-p) ≤ 10. As one participant did not complete the SAD
and Specific Phobia subsections of the MINI, the total sample size for
these disorders was 179.
For the reporting and treatment of anxiety, percentages were cal-
culated to determine how many of those who met criteria for a
threshold/subthreshold anxiety disorder had an indication of anxiety
on file and were receiving medication or psychological treatment. As
MMSE scores for participants with no threshold/subthreshold anxiety
disorders were found to have significant kurtosis (z-score of> 1.96)
(Field, 2009), non-parametric Mann-Whitney U tests were used to de-
termine whether there was a difference in level of cognitive functioning
between those diagnosed with a threshold/subthreshold anxiety dis-




Demographic and clinical characteristics of the sample are shown in
Table 2. The sample comprised 60 males (33.3%) and 120 (66.7%)
females, with a mean age of 85.4 years (SD = 7.4). The age distribution
and gender ratio of the sample was typical of residents of RACFs in
Australia (Australian Institute of Health and Welfare, 2015).
3.2. Prevalence of threshold and subthreshold anxiety disorders
3.2.1. Threshold anxiety disorders
Using the MINI for DSM-5, the overall prevalence rate of any current
threshold anxiety disorder was 19.4% (95% CI: 13.6–25.2%); with 35
participants meeting criteria for one or more disorders (Table 3). Most
participants met criteria for one threshold disorder (n = 29, 82.9%),
five participants (14.3%) met criteria for two, and one participant met
criteria for three (panic disorder, agoraphobia, and GAD; 2.9%). GAD
was the most prevalent threshold disorder, followed by specific phobia.
There was no significant difference in level of cognitive functioning
between participants with a threshold anxiety disorder (Mdn = 26.00,
Range = 11, n = 35) and those without (Mdn = 25.00, Range = 12, n
= 145), z = 0.114, p = 0.909.
3.2.2. Subthreshold anxiety disorders
Overall prevalence of any current subthreshold anxiety disorder was
11.7% (95% CI: 7.0 – 16.4%); with 21 participants meeting criteria for
one or more disorders. In eight cases the subthreshold disorder co-oc-
curred with one or more threshold anxiety disorders, while the re-
maining participants met criteria for one subthreshold disorder only.
Table 1
Criteria for subthreshold anxiety disorders (According to criteria of Angst et al., 1997 and Heun et al., 2000).
Anxiety disorder Subthreshold criteria
Panic disorder A subthreshold panic attack (a panic attack with one or more physical symptoms) during the last 4 weeks.
Agoraphobia Unreasonable fear in places or situations from which it is difficult to leave during the last 4 weeks and at least some avoidance or symptoms of anxiety.
Specific phobia Persistent fear of circumscribed stimulus during the last 4 weeks and at least some avoidance or consequences.
Social anxiety disorder Persistent fear of situations in which a person is exposed to social interactions during the last 4 weeks and at least some avoidance or consequences.
GAD Unrealistic anxiety or worry about two or more life situations during the last 6 months and at least one physical or vegetative symptom, and person finds
it distressing.
GAD, Generalised Anxiety Disorder.
Table 2
Demographic and clinical characteristics of the sample (N = 180).
Characteristic N % Mean SD Range










Years of education 10.8 3.3 1–21
Cognitive functioning (MMSE score) 24.7 3.6 18–30
Length of stay (years) 2.6 2.5 0.2–12.6
SD, standard deviation; MMSE, Mini-Mental State Examination.
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No significant differences were found in level of cognitive functioning
between participants with a subthreshold anxiety disorder (Mdn =
26.00, Range = 11, n = 21) and those without (Mdn = 25.00, Range
= 12, n = 159), z = 0.678, p = 0.498.
3.3. Prevalence of MDD and comorbid anxiety and MDD
Fifteen participants met criteria for MDD (8.3%; 95% CI:
4.8–12.3%), with the prevalence of comorbid MDD and any threshold
anxiety disorder found to be 6.7% (95% CI: 3–10.4%). Of those with
threshold anxiety, 34.3% also received a diagnosis of MDD, with panic
disorder the diagnosis with the highest rate of comorbid MDD (100%).
Fifty percent of participants with agoraphobia, 43.8% of those with
GAD, and 22.2% of those with specific phobia also had a diagnosis of
MDD. Only four participants (2.2%) in the total sample had comorbid
subthreshold anxiety and MDD.
3.4. Reporting and treatment of anxiety
3.4.1. Reporting of any threshold/subthreshold anxiety disorder
Less than half of participants with a threshold or subthreshold an-
xiety disorder had any indication of anxiety on file (i.e., the terms
‘anxiety’, ‘anxiety disorder’, ‘anxious’ were included in the list of
medical conditions or on behavioural charts) (Table 4).
3.4.2. Treatment of any threshold/subthreshold anxiety disorder
Of the 56 participants with a threshold or subthreshold anxiety
disorder, more than half were receiving a treatment that was poten-
tially prescribed for anxiety (see Table 4). Similar treatment rates were
found for threshold and subthreshold conditions. Psychological treat-
ment had been provided to 8.6% of participants with a threshold an-
xiety disorder but to no participants with a subthreshold diagnosis.
Mann-Whitney tests revealed no significant differences in cognitive
function between participants who were and were not receiving anti-
depressants within the overall sample (p = 0.311), and for those with a
threshold (p = 0.123) or subthreshold disorder (p = 1.000). Similarly,
no significant differences in cognition were found between those who
were and were not receiving benzodiazepines (overall sample: p =
0.895; those with a threshold anxiety disorder: p = 0.606; those with a
subthreshold anxiety disorder: p = 0.310) or antipsychotics (overall
sample: p = 0.427; those with a threshold anxiety disorder: p = 0.612;
those with a subthreshold anxiety disorder: p = 0.857).
3.4.3. Reporting of anxiety in participants with a specific threshold/
subthreshold anxiety disorder
All participants with threshold panic disorder and agoraphobia had
an indication of anxiety on file, as did the majority of participants with
threshold SAD (Table 5). Less than half with threshold GAD and only
18.2% with threshold specific phobia had any record of anxiety. Par-
ticipants with subthreshold GAD and specific phobia had the highest
rates of anxiety recorded in their file. Half the participants with sub-
threshold SAD and none with subthreshold agoraphobia had an in-
dication of anxiety noted.
3.4.4. Treatment of anxiety in participants with a specific threshold/
subthreshold anxiety disorder
As shown in Table 5, the most common treatment for participants
with specific threshold anxiety disorders were benzodiazepines; with
100% of participants with panic disorder and SAD, 80.0% of those with
agoraphobia, and 65.0% of those with GAD prescribed this medication.
Anti-depressants were also commonly prescribed. Antipsychotics were
uncommonly prescribed. Participants with threshold specific phobia
were the least likely to have received treatment.
At least half of the participants with a threshold anxiety disorder
received a combination of anti-depressants and benzodiazepines; with
this being the case for threshold SAD, agoraphobia, and GAD.
Participants with threshold panic disorder or specific phobia were ty-
pically prescribed a benzodiazepine only. Participants with a sub-
threshold anxiety disorder who were receiving treatment were also
typically prescribed a combination of anti-depressants and benzodia-
zepines.
4. Discussion
To the authors’ knowledge, this study is the first in 10 years to ex-
amine the prevalence of anxiety disorders and comorbid MDD in
RACFs, and only the second published study to determine the reporting
and treatment rates of anxiety by GPs, other medical practitioners, and
facility staff.
4.1. The prevalence of overall and specific threshold/subthreshold anxiety
disorders
Overall, 26.7% of the sample met criteria for a threshold or sub-
threshold anxiety disorder. There was a high overall prevalence of
threshold anxiety disorders, with 19.4% meeting DSM-5 (APA, 2013)
criteria. This falls into the upper range of prevalence estimates reported
by previous RACF studies; where rates were between 3.2–20.0%
(Arvaniti et al., 2005; Forsell and Winblad, 1997; Junginger et al.,
1993; Smalbrugge et al., 2005b). Compared to population-based studies
(where prevalence estimates range between 1.4–17.0% (Creighton
et al., 2015)), the current study provides further evidence that older
adults living in residential care are more prone to experience anxiety,
indicating that the condition remains a widespread and significant issue
within this setting.
In agreement with previous late-life research (Bryant et al., 2008;
Krasucki et al., 1999), threshold GAD (11.1%) and specific phobia
(6.1%) were the two most common anxiety disorders. Again, rates of
both disorders in the current RACF sample were in the upper range or
higher than previous (Bland et al., 1988; Cheok et al., 1996; Class et al.,
1996; Junginger et al., 1993; Smalbrugge et al., 2005). The prevalence
Table 3
Prevalence rates and 95% Confidence Intervals of Threshold and Subthreshold DSM-5
Anxiety Disorders among Residents of Aged Care Facilities (n = 180).




N % N %
(95% CI) (95% CI)
Social anxiety disorderb 3 1.7 6 3.3
(0 –5.0) (1.1 – 7.3)
Panic disorder 3 1.7 0 0
(0 – 2.6) (0 – 16.2)
Agoraphobiac 5 2.8 7 3.9
(1.0 – 6.6) (1.8 – 8)
Specific phobiab,d 11 6.1 5 2.8
(2.6 – 9.6) (1.0 – 6.6)
GAD 20 11.1 6 3.3
(6.5 – 15.7) (1.4 – 7.3)
Any anxiety disorder 35 19.4 21 11.7
(13.6 – 25.2) (7.0 – 16.4)
CI, confidence interval; GAD, Generalised Anxiety Disorder.
a A threshold anxiety disorder diagnosis excludes the diagnosis of the same subthres-
hold disorder.
b N = 179.
c Most commonly cited situations to evoke anxiety symptoms were being in a crowd
(threshold: 44.4%; subthreshold: 40.0%), being in an enclosed space (threshold: 33.3%;
subthreshold: 30.0%), and being away from home (threshold: 22.2%; subthreshold:
20.0%).
d Phobic stimuli included: the natural environment (threshold: 45.5%; subthreshold:
60.0%), animals/insects (threshold: 18.2%; subthreshold: 0%), blood-injection-injury
(threshold: 18.2%; subthreshold: 0%), situational factors (threshold: 18.2%; subthres-
hold: 40.0%).
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of GAD was also higher than that found in community-dwelling elderly
samples (Beekman et al., 1998; Byers et al., 2010). As chronic physical
illnesses and functional limitations have been found to be significantly
associated with GAD (Beekman et al., 1998; Van Balkom et al., 2000),
the higher rate of this disorder within the current aged care sample may
be explained by the fact that this population is typically more frail,
functionally dependent, and medically complex than their community-
dwelling counterparts (Australian Institute of Health and Welfare,
2015).
Agoraphobia (2.7%), SAD (1.7%), and panic disorder (1.7%) were
found to be relatively uncommon, which is consistent with the limited
previous research in RACFs (Cheok et al., 1996; Jervis and Manson,
2007; Smalbrugge et al., 2005b). Similar estimates have been found
within community elderly samples (e.g., Beekman et al., 1998;
Kirmizioglu et al., 2009). Given that older adults (particularly RACF
residents) often have fewer obligations and are typically more restricted
in their daily activities (De Bellis, 2010), it may be that they find it
easier to avoid activities and situations that evoke the fear and anxiety
associated with these disorders.
Unlike previous studies on community elderly samples (Grenier
et al., 2011; Heun et al., 2000), the current study found subthreshold
anxiety disorders to be less prevalent (11.7%) than threshold disorders.
Nonetheless, a substantial proportion of the sample met criteria for
subthreshold anxiety disorders, with agoraphobia (3.9%), GAD (3.3%),
and SAD (3.3%) being the most common.
The prevalence rates found in the current sample appear to be
higher than those in prior research. It should be noted that most pre-
vious RACF studies utilised hierarchical rules or did not include all
anxiety disorders in their overall prevalence (e.g., Bland et al., 1988;
Cheok et al., 1996), and therefore may have underestimated the true
prevalence of anxiety. Moreover, as previous studies on anxiety in
RACFs were conducted over 10 years ago, it is possible that the higher
prevalence estimations found in the current study are due to cohort or
cultural differences regarding the acceptability of disclosing symptoms.
Thus, it may be that this study's findings are a more accurate reflection
of the true prevalence of anxiety within the current RACF population.
Another explanation for higher estimations could be the current
study's use of DSM-5 (APA, 2013) and the MINI. Several important
Table 4
Diagnosis of any DSM-5 threshold/subthreshold anxiety disorder, indication of anxiety on file and treatment of anxious participants.





















Normal 22/115 8/22 15/22 12/22 2/22 2/22 6/22
(MMSE = ≥ 24) (19.1%) (36.4%) (68.2%) (54.5%) (9.1%) (9.1%) (27.3%)
Mild impairment 13/65 6/13 5/13 9/13 0/13 1/13 2/13
(MMSE = 18–23) (20.0%) (46.2%) (38.5%) (69.2%) (0%) (7.7%) (15.4%)
Total 35/180 14/35 20/35 21/35 2/35 3/35 8/35
(19.4%) (40.0%) (57.1%) (60.0%) (5.7%) (8.6%) (22.9%)
Subthreshold anxiety disorders
Normal 15/115 6/15 10/15 9/15 1/15 0/15 3/15




6/65 2/6 3/6 3/6 0/6 0/6 1/6
(9.2%) (33.3%) (50.0%) (50.0%) (0%) (0%) (16.7%)
Total 21/180 8/21 13/21 12/21 1/21 0/21 4/21
(11.7%) (38.1%) (61.9%) (57.1%) (4.8%) (0%) (19.0%)
PRN, pro re nata or ‘as needed’; MMSE = Mini-Mental State Examination.
Table 5
Diagnosis of specific DSM-5 threshold/subthreshold anxiety disorder, indication of anxiety on file and treatment of anxious participants.
















Panic disorder 3/3 1/3 3/3 0/3 0/3 0/3
(100%) (33.3%) (100%) (0%) (0%) (0%)
Social anxiety
disorder
2/3 2/3 3/3 0/3 0/3 0/3
(66.7%) (66.7%) (100%) (0%) (0%) (0%)
Agoraphobia 5/5 4/5 4/5 1/5 1/5 1/5
(100%) (80.0%) (80.0%) (20.0%) (20.0%) (20.0%)
Specific phobia 2/11 5/11 5/11 0/11 1/11 3/11
(18.2%) (45.5%) (45.5%) (0%) (9.1%) (27.3%)
GAD 8/20 13/20 13/20 1/20 2/20 4/20




3/6 4/6 4/6 1/6 0/6 1/6
(50.0%) (66.7%) (66.7%) (16.7%) (0%) (16.7%)
Agoraphobia 0/7 5/7 3/7 0/7 0/7 1/7
(0%) (71.4%) (42.9%) (0%) (0%) (14.3%)
Specific phobia 3/5 4/5 4/5 1/5 0/5 1/5
(60.0%) (80.0%) (80.0%) (20.0%) (0%) (20.0%)
GAD 4/6 3/6 4/6 1/6 0/6 1/6
(66.7%) (50.0%) (66.7%) (16.7%) (0%) (16.7%)
Note. Subthreshold panic disorder was not included in the table as no participants met criteria for this diagnosis.
PRN, pro re nata or ‘as needed’; GAD, Generalised Anxiety Disorder.
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changes were made to anxiety disorder criteria in DSM-5; with a
broadening of feared consequences in SAD and removal of the re-
quirement for individuals to recognize their anxiety is excessive or
unreasonable for a diagnosis of SAD, agoraphobia, and specific phobia
(APA, 2013). As older adults with anxiety often have poor insight into
their symptoms and frequently misattribute them to medical etiology
(Lenze and Wetherell, 2011), a number may not have met criteria using
previous versions of the DSM. Moreover, the MINI was designed to be
slightly overinclusive to decrease the chances of false negatives
(Sheehan et al., 1997, 1998) and so may have contributed to higher
prevalence rates.
4.2. Threshold/subthreshold anxiety disorders and cognitive impairment
Previous research reported mixed findings on the relationship be-
tween cognitive impairment and anxiety (Cheok et al., 1996;
Smalbrugge et al., 2005b). In this study, mild cognitive impairment was
not found to be significantly associated with the presence of threshold
or subthreshold anxiety disorders, which is consistent with research by
Cheok et al. (1996) and Neville and Teri (2011). Some research has
found higher levels of cognitive functioning to be significantly asso-
ciated with anxiety (Smalbrugge et al., 2005b) while others have re-
ported higher rates of anxiety among those with lower cognitive func-
tioning (Parmelee et al., 1993; Zuidema et al., 2009). Given that more
than half of the RACF population has dementia (AIHW, 2015), further
research is needed to clarify the precise relationship between anxiety
and cognitive functioning among RACF residents.
4.3. Comorbid anxiety and MDD
Overall, comorbid threshold anxiety and MDD was found in 6.7% of
the sample. Thirty-four percent of participants with a threshold anxiety
disorder and 19.0% with subthreshold anxiety had comorbid MDD,
which is consistent with previous research in both RACF (Parmelee
et al., 1993; Smalbrugge et al., 2005a) and community samples
(Beekman et al., 1998; Schoevers et al., 2003). Given that anxiety ty-
pically precedes depression (Wetherell et al., 2001), the high rates of
comorbidity in residents with anxiety is not surprising and suggests the
lower comorbidity rate found with subthreshold anxiety disorders may
be because the anxiety and its consequences are not yet severe enough
to evoke depressive symptoms. Further RACF research (particularly
longitudinal studies) is needed to clarify the prevalence of comorbid
threshold/subthreshold anxiety and depression in this population and
determine the direction of their relationship.
4.4. Recording and treatment of anxiety
Less than half the participants with a threshold or subthreshold
anxiety disorder had any indication of anxiety on file, suggesting that
the condition is significantly under-reported. This is in contrast to
treatment rates, with the majority found to have been prescribed an
anti-depressant and/or benzodiazepine. For the majority of participants
the authors were unable to identify whether their medications were
used to treat anxiety or some other condition (e.g., depression, agita-
tion). However, given the significant under-reporting of anxiety in this
study, it may be that the medication was not primarily prescribed to
treat participants’ anxiety in some instances. Therefore, this study may
have overestimated the true treatment rate of anxiety.
Another explanation for the under-reporting of anxiety in the con-
text of high prescription rates may be that GPs are prescribing medi-
cations for anxiety symptoms, but failing to record their detection in
residents’ files. This may be because GPs perceive anxiety to be a
normal part of ageing and/or response to residing in RACFs, and sub-
sequently believe no formal diagnosis or record on file is needed.
Previous studies examining the treatment and detection of depression in
RACFs have reported similar findings (Cohen et al., 2003; Gruber-
Baldini et al., 2005; Lustenberger et al., 2011), suggesting that under-
diagnosis and reporting of psychiatric conditions in aged care residents
is common. This suggests a valid screening measure and specialised
training in the recognition of anxiety for RACF nursing staff may be
beneficial.
This study confirms previous findings that psychotropic medication
and polypharmacy is typically used as first line treatment for mental
health concerns in RACF residents (Davison et al., 2007, 2012), despite
the potential adverse side-effects observed in frail older adults (Hajjar
et al., 2007). Reasons for overdependence on pharmacological ap-
proaches may include a perceived negative social stigma associated
with seeking psychological support, lack of staff awareness of mental
health, inadequate funding, and poor access to psychological care
providers (Davison et al., 2016). However, with growing evidence for
the effectiveness of psychological intervention in treating anxiety and
depression in elderly residents (Wells et al., 2014), RACF staff and GPs
should be educated on the potential benefits of psychotherapy for this
population.
Agoraphobia and panic disorder were the most commonly detected
and treated specific threshold anxiety disorders. One reason for this
may be that the symptoms associated with these disorders are overt and
behaviourally-based (i.e., panic attacks, avoidance of specific situa-
tions), meaning that staff are more likely to notice them and their im-
pact on functioning. Panic disorder appeared to be most commonly
treated with benzodiazepines (100.0%), which is consistent with pre-
vious research (Van Balkom et al., 2000). Threshold specific phobia
appeared to be the least commonly detected and treated disorder,
possible due to the limited impact of symptoms on residents’ daily life.
Although participants with normal cognition appeared to have
slightly higher treatment rates, no significant difference was found in
the treatment of anxiety between residents with normal cognitive
function and mild impairment. This finding is similar to a previous
study examining treatment rates of depression in RACFs (Davison et al.,
2007), however the current study experienced the same methodological
limitations of a small sample size and exclusion of residents with higher
levels of cognitive impairment. Further studies with a larger sample size
that includes residents with moderate/severe cognitive deficits are
needed.
4.5. Study limitations
There are a number of limitations to this study. First, a cross-sec-
tional design was used, which limits the interpretation of findings as
causal inferences cannot be made between anxiety and cognition.
Second, given that participation was voluntary and those with sig-
nificant cognitive impairment were excluded, the sample may suffer
from selection bias and limit generalizability of findings. Third, while
the sample size was likely adequate to detect prevalence of overall
anxiety, the final sample was a small proportion of the total population
available. Moreover, the small cell sizes and large confidence intervals
for specific anxiety disorders means findings for prevalence, reporting,
and treatment must be interpreted with caution. Lastly, the current
study did not assess for separation anxiety disorder, selective mutism,
substance/medication-induced anxiety disorder, or anxiety disorder
due to another medical condition. As well as being mindful not to
overburden participants with questions, separation anxiety and selec-
tive mutism were not considered vital given they seldom persist into
adulthood (Garcia et al., 2004; Shear et al., 2006), while substance/
medication-induced anxiety disorder or anxiety disorder due to another
medical condition were not assessed by the MINI for DSM-5. The ex-
clusion of these disorders may have resulted in an underestimation of
the prevalence of anxiety disorders within this setting.
5. Conclusions
Although, due to variable prevalence estimates across studies the
A.S. Creighton et al. Journal of Affective Disorders 227 (2018) 416–423
421
true prevalence of specific anxiety disorders among RACF residents
remains uncertain, this study confirms the high rate of anxiety among
this frail and growing population. Despite this, anxiety appears to re-
main largely under-reported and undertreated with psychological
therapies. From a clinical perspective, this highlights the need for an
increase in overall awareness of both anxiety and the range of effective
treatment options among GPs and RACF staff, and suggests the identi-
fication and use of a valid screening measure may aid in detection and
therefore improved outcomes for residents. Thus, as well as examining
the prevalence of threshold/subthreshold anxiety in aged care through
the use of a prospective design and inclusion of residents with more
severe cognitive impairment, research identifying a reliable, valid, and
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